annual EBIT:
-$378.94M-$143.34M(-60.84%)Summary
- As of today (August 20, 2025), RNA annual earnings before interest & taxes is -$378.94 million, with the most recent change of -$143.34 million (-60.84%) on December 31, 2024.
- During the last 3 years, RNA annual EBIT has fallen by -$260.88 million (-220.99%).
- RNA annual EBIT is now -3509.60% below its all-time high of -$10.50 million, reached on December 31, 2018.
Performance
RNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$171.14M-$39.63M(-30.13%)Summary
- As of today (August 20, 2025), RNA quarterly earnings before interest & taxes is -$171.14 million, with the most recent change of -$39.63 million (-30.13%) on June 1, 2025.
- Over the past year, RNA quarterly EBIT has dropped by -$88.52 million (-107.13%).
- RNA quarterly EBIT is now -7761.37% below its all-time high of -$2.18 million, reached on March 31, 2019.
Performance
RNA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$521.78M-$88.52M(-20.43%)Summary
- As of today (August 20, 2025), RNA TTM earnings before interest & taxes is -$521.78 million, with the most recent change of -$88.52 million (-20.43%) on June 1, 2025.
- Over the past year, RNA TTM EBIT has dropped by -$236.60 million (-82.97%).
- RNA TTM EBIT is now -23867.98% below its all-time high of -$2.18 million, reached on March 31, 2019.
Performance
RNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RNA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.8% | -107.1% | -83.0% |
| 3 y3 years | -221.0% | -269.6% | -251.2% |
| 5 y5 years | -2084.4% | -1541.7% | -1783.6% |
RNA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -221.0% | at low | -280.9% | at low | -251.2% | at low |
| 5 y | 5-year | -2084.4% | at low | -1541.7% | at low | -1783.6% | at low |
| alltime | all time | -3509.6% | at low | -7761.4% | at low | <-9999.0% | at low |
RNA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$171.14M(+30.1%) | -$521.78M(+20.4%) |
| Mar 2025 | - | -$131.52M(+8.7%) | -$433.27M(+14.3%) |
| Dec 2024 | -$378.94M(+60.8%) | -$120.99M(+23.3%) | -$378.94M(+16.7%) |
| Sep 2024 | - | -$98.13M(+18.8%) | -$324.69M(+13.9%) |
| Jun 2024 | - | -$82.63M(+7.0%) | -$285.18M(+11.8%) |
| Mar 2024 | - | -$77.19M(+15.6%) | -$255.19M(+8.3%) |
| Dec 2023 | -$235.60M(+31.7%) | -$66.74M(+13.8%) | -$235.60M(+6.1%) |
| Sep 2023 | - | -$58.63M(+11.4%) | -$222.08M(+6.6%) |
| Jun 2023 | - | -$52.63M(-8.6%) | -$208.38M(+3.1%) |
| Mar 2023 | - | -$57.60M(+8.2%) | -$202.05M(+12.9%) |
| Dec 2022 | -$178.91M | -$53.23M(+18.5%) | -$178.91M(+8.9%) |
| Sep 2022 | - | -$44.93M(-3.0%) | -$164.24M(+10.5%) |
| Jun 2022 | - | -$46.30M(+34.4%) | -$148.59M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$34.46M(-10.6%) | -$128.65M(+9.0%) |
| Dec 2021 | -$118.05M(+167.4%) | -$38.55M(+31.6%) | -$118.05M(+23.3%) |
| Sep 2021 | - | -$29.28M(+11.0%) | -$95.78M(+22.9%) |
| Jun 2021 | - | -$26.37M(+10.5%) | -$77.94M(+25.7%) |
| Mar 2021 | - | -$23.86M(+46.6%) | -$62.00M(+40.4%) |
| Dec 2020 | -$44.15M(+154.5%) | -$16.27M(+42.3%) | -$44.15M(+30.1%) |
| Sep 2020 | - | -$11.44M(+9.7%) | -$33.93M(+22.5%) |
| Jun 2020 | - | -$10.43M(+73.5%) | -$27.70M(+30.8%) |
| Mar 2020 | - | -$6.01M(-0.9%) | -$21.18M(+22.1%) |
| Dec 2019 | -$17.35M(+65.2%) | -$6.06M(+16.5%) | -$17.35M(+53.7%) |
| Sep 2019 | - | -$5.21M(+33.5%) | -$11.28M(+85.7%) |
| Jun 2019 | - | -$3.90M(+79.2%) | -$6.08M(+179.2%) |
| Mar 2019 | - | -$2.18M | -$2.18M |
| Dec 2018 | -$10.50M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual EBIT year-on-year change?
- What is Avidity Biosciences, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly EBIT year-on-year change?
- What is Avidity Biosciences, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM EBIT year-on-year change?
What is Avidity Biosciences, Inc. annual earnings before interest & taxes?
The current annual EBIT of RNA is -$378.94M
What is the all time high annual EBIT for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual earnings before interest & taxes is -$10.50M
What is Avidity Biosciences, Inc. annual EBIT year-on-year change?
Over the past year, RNA annual earnings before interest & taxes has changed by -$143.34M (-60.84%)
What is Avidity Biosciences, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of RNA is -$171.14M
What is the all time high quarterly EBIT for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly earnings before interest & taxes is -$2.18M
What is Avidity Biosciences, Inc. quarterly EBIT year-on-year change?
Over the past year, RNA quarterly earnings before interest & taxes has changed by -$88.52M (-107.13%)
What is Avidity Biosciences, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of RNA is -$521.78M
What is the all time high TTM EBIT for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM earnings before interest & taxes is -$2.18M
What is Avidity Biosciences, Inc. TTM EBIT year-on-year change?
Over the past year, RNA TTM earnings before interest & taxes has changed by -$236.60M (-82.97%)